RxDoctor Payments Data

Romee Gandhi

Family · Clark, NJNPI 1407227408

Payments from drug & device makers

$6,999in general payments, 2019–2025

Across 440 payments — averaging $15.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$750
  • Amgen$735
  • Incyte Corporation$634
  • Sun Pharmaceutical Industries Inc.$576
  • Regeneron Healthcare Solutions, Inc.$485
  • Mayne Pharma Commercial LLC$329
  • plus $3K from 25 others
$1,279in research payments, 2019–2025

Across 2 payments — averaging $639.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Almirall LLC$1K

What the payments were for

  • Food & beverage$6,59894%
  • Education$4016%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,999 in reported general payments places this provider in the 95th percentile of 2,692 family providers in New Jersey.

See all family providers in New Jersey

Medicare billing

Part B allowed, 2024
$51,281
Medicare patients
207
Services billed
614

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate36$1,339
Azelaic Acid15$1,128
Ketoconazole53$990
Clindamycin Phosphate17$582
Mupirocin29$237
Doxycycline Hyclate13$219
Triamcinolone Acetonide27$147
Hydrocortisone18$82

Paid to pharmacies, not to this prescriber.

Other family in Clark

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →